Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1948 1
1950 2
1951 1
1952 2
1953 3
1954 5
1955 1
1956 6
1957 1
1958 4
1959 1
1960 3
1961 1
1962 1
1963 2
1964 1
1965 1
1966 4
1967 2
1968 1
1971 1
1972 1
1973 1
1974 2
1978 3
1980 1
1981 1
1982 1
1986 1
1991 2
1993 2
1994 1
1995 1
1997 2
1998 2
1999 7
2000 5
2001 2
2002 2
2003 1
2004 4
2005 1
2007 1
2008 1
2012 5
2013 1
2018 4
2019 4
2020 2
2021 3
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

109 results

Results by year

Filters applied: . Clear all
Page 1
Rationale and design of ENDEAVOR: A sequential phase 2b-3 randomized clinical trial to evaluate the effect of myeloperoxidase inhibition on symptoms and exercise capacity in heart failure with preserved or mildly reduced ejection fraction.
Lund LH, Lam CSP, Pizzato PE, Gabrielsen A, Michaëlsson E, Nelander K, Ericsson H, Holden J, Folkvaljon F, Mattsson A, Collén A, Aurell M, Whatling C, Baldus S, Drelich G, Goudev A, Merkely B, Bergh N, Shah SJ. Lund LH, et al. Among authors: ericsson h. Eur J Heart Fail. 2023 Sep;25(9):1696-1707. doi: 10.1002/ejhf.2977. Epub 2023 Aug 22. Eur J Heart Fail. 2023. PMID: 37470101 Clinical Trial.
[A doubtful reform].
Ericsson H. Ericsson H. Lakartidningen. 1978 Nov 29;75(48):4459-60. Lakartidningen. 1978. PMID: 723326 Swedish. No abstract available.
Antibiotic sensitivity testing. 1971.
Ericsson HM, Sherries JC. Ericsson HM, et al. APMIS. 2007 May;115(5):609-18; discussion 619-20. doi: 10.1111/j.1600-0463.2007.apm_690a.x. APMIS. 2007. PMID: 17504424 No abstract available.
Early Clinical Experience With AZD4831, A Novel Myeloperoxidase Inhibitor, Developed for Patients With Heart Failure With Preserved Ejection Fraction.
Nelander K, Lagerstrom-Fermer M, Amilon C, Michaëlsson E, Heijer M, Kjaer M, Russell M, Han D, Lindstedt EL, Whatling C, Gan LM, Ericsson H. Nelander K, et al. Among authors: ericsson h. Clin Transl Sci. 2021 May;14(3):812-819. doi: 10.1111/cts.12859. Epub 2021 May 2. Clin Transl Sci. 2021. PMID: 32770730 Free PMC article. Clinical Trial.
Mass Balance and Absorption, Distribution, Metabolism, and Excretion Properties of Balcinrenone following Oral Administration in Combination with Intravenous Microtracer in Healthy Subjects.
Lindmark B, Li XQ, Bhattacharya C, Housler G, Heijer M, Bragg RA, Gränfors M, Pelay-Gimeno M, Vaes WHJ, Menakuru S, Pizzato PE, Ericsson H, Johansson S. Lindmark B, et al. Among authors: ericsson h. Drug Metab Dispos. 2023 Aug;51(8):995-1004. doi: 10.1124/dmd.122.001240. Epub 2023 Jul 5. Drug Metab Dispos. 2023. PMID: 37407094
Clinical safety, tolerability, pharmacokinetics and effects on urinary electrolyte excretion of AZD9977, a novel, selective mineralocorticoid receptor modulator.
Erlandsson F, Albayaty M, Chialda L, Ericsson H, Amilon C, Nelander K, Jansson-Löfmark R, Wernevik L, Kjaer M, Bamberg K, Hartleib-Geschwindner J. Erlandsson F, et al. Among authors: ericsson h. Br J Clin Pharmacol. 2018 Jul;84(7):1486-1493. doi: 10.1111/bcp.13562. Epub 2018 Apr 22. Br J Clin Pharmacol. 2018. PMID: 29468715 Free PMC article. Clinical Trial.
109 results